Clinical Trials Browser

Phase 1 × Completed × Leukemia, Myeloid × Clear all

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Preleukemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04714372 2024-10-24

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Phase 1 Completed

9 enrolled 16 charts

Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT02916979 2023-10-18

FluBuATG

Phase 1 Completed

20 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Primary Myelofibrosis

NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

Phase 1 Completed

24 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00780104 2019-07-12

UPCC 02407

Phase 1 Completed

16 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

NCT00718159 2019-01-10

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Phase 1 Completed

23 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Recurrence, Thrombocythemia, Essential, Leukemia, Myeloid, Acute

NCT02098967 2018-05-17

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Phase 1 Completed

68 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Neoplasms

NCT01380756 2017-11-06

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Phase 1 Completed

35 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms, Hematologic Neoplasms

NCT01677780 2017-07-07

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Phase 1 Completed

11 enrolled

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myeloid, Neoplasms

NCT00943943 2017-03-29

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

Phase 1 Completed

33 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01321346 2015-11-24

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Phase 1 Completed

30 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Leukemia, Myeloid, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00497991 2010-12-08

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

Phase 1 Completed

65 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT00001748 2008-03-04

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Phase 1 Completed

35 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Myeloid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Clinical Trials

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

FluBuATG

AC220 for Children With Relapsed/Refractory ALL or AML

UPCC 02407

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies